The Influenza Virus Protein PB1-F2 Inhibits the Induction of Type I Interferon at the Level of the MAVS Adaptor Protein

English version České info

PB1-F2 is a 90 amino acid protein that is expressed from the +1 open reading frame in the PB1 gene of some influenza A viruses and has been shown to contribute to viral pathogenicity. Notably, a serine at position 66 (66S) in PB1-F2 is known to increase virulence compared to an isogenic virus with an asparagine (66N) at this position. Recently, we found that an influenza virus expressing PB1-F2 N66S suppresses interferon (IFN)-stimulated genes in mice. To characterize this phenomenon, we employed several in vitro assays. Overexpression of the A/Puerto Rico/8/1934 (PR8) PB1-F2 protein in 293T cells decreased RIG-I mediated activation of an IFN-β reporter and secretion of IFN as determined by bioassay. Of note, the PB1-F2 N66S protein showed enhanced IFN antagonism activity compared to PB1-F2 wildtype. Similar observations were found in the context of viral infection with a PR8 PB1-F2 N66S virus. To understand the relationship between NS1, a previously described influenza virus protein involved in suppression of IFN synthesis, and PB1-F2, we investigated the induction of IFN when NS1 and PB1-F2 were co-expressed in an in vitro transfection system. In this assay we found that PB1-F2 N66S further reduced IFN induction in the presence of NS1. By inducing the IFN-β reporter at different levels in the signaling cascade, we found that PB1-F2 inhibited IFN production at the level of the mitochondrial antiviral signaling protein (MAVS). Furthermore, immunofluorescence studies revealed that PB1-F2 co-localizes with MAVS. In summary, we have characterized the anti-interferon function of PB1-F2 and we suggest that this activity contributes to the enhanced pathogenicity seen with PB1-F2 N66S- expressing influenza viruses.

Vyšlo v časopise: The Influenza Virus Protein PB1-F2 Inhibits the Induction of Type I Interferon at the Level of the MAVS Adaptor Protein. PLoS Pathog 7(6): e32767. doi:10.1371/journal.ppat.1002067
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002067

Souhrn

Zdroje

1. JohnsonNPMuellerJ 2002 Updating the accounts: global mortality of the 1918–1920 “Spanish” influenza pandemic. Bull Hist Med 76 105 115

2. ChenWCalvoPAMalideDGibbsJSchubertU 2001 A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 7 1306 1312

3. ZamarinDOrtigozaMBPaleseP 2006 Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 80 7976 7983

4. ConenelloGMZamarinDPerroneLATumpeyTPaleseP 2007 A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 3 1414 1421

5. ConenelloGMTisoncikJRRosenzweigEVargaZTPaleseP 2011 A Single N66S Mutation in the PB1-F2 Protein of Influenza A Virus Increases Virulence by Inhibiting the Early Interferon Response In Vivo. J Virol 85 652 662

6. RehwinkelJTanCPGoubauDSchulzOPichlmairA 2010 RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140 397 408

7. PichlmairASchulzOTanCPNaslundTILiljestromP 2006 RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314 997 1001

8. OpitzBRejaibiADauberBEckhardJVinzingM 2007 IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 9 930 938

9. WatheletMGLinCHParekhBSRoncoLVHowleyPM 1998 Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell 1 507 518

10. KawaiTAkiraS 2007 Antiviral signaling through pattern recognition receptors. J Biochem 141 137 145

11. RodriguezJJParisienJPHorvathCM 2002 Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J Virol 76 11476 11483

12. ShawMLGarcia-SastreAPalesePBaslerCF 2004 Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J Virol 78 5633 5641

13. PrinsKCCardenasWBBaslerCF 2009 Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J Virol 83 3069 3077

14. KochsGGarcia-SastreAMartinez-SobridoL 2007 Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 81 7011 7021

15. DonelanNRBaslerCFGarcia-SastreA 2003 A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice. J Virol 77 13257 13266

16. WangWRiedelKLynchPChienCYMontelioneGT 1999 RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 5 195 205

17. WangXLiMZhengHMusterTPaleseP 2000 Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol 74 11566 11573

18. TalonJHorvathCMPolleyRBaslerCFMusterT 2000 Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74 7989 7996

19. LudwigSWangXEhrhardtCZhengHDonelanN 2002 The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors. J Virol 76 11166 11171

20. GackMUAlbrechtRAUranoTInnKSHuangIC 2009 Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5 439 449

21. LiSMinJYKrugRMSenGC 2006 Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349 13 21

22. BergmannMGarcia-SastreACarneroEPehambergerHWolffK 2000 Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol 74 6203 6206

23. GraefKMVreedeFTLauYFMcCallAWCarrSM 2010 The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with MAVS and inhibiting IFN-{beta} expression. J Virol 84 8433 45

24. IwaiAShiozakiTKawaiTAkiraSKawaokaY 2010 Influenza A virus polymerase inhibits type I interferon induction by binding to interferon {beta} promoter stimulator 1. J Biol Chem 285 32064 74

25. PalesePShawML 2006 Orthomyxoviridae: The viruses and their replication. Fields Virology. 5th edition Philadelphia Lippincott Williams & Wilkins 1648 1689

26. ZamarinDGarcia-SastreAXiaoXWangRPaleseP 2005 Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 1 e4

27. McAuleyJLChipukJEBoydKLVan De VeldeNGreenDR 2010 PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog 6 e1001014

28. McAuleyJLHornungFBoydKLSmithAMMcKeonR 2007 Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2 240 249

29. MazurIAnhlanDMitznerDWixlerLSchubertU 2008 The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol 10 1140 1152

30. McAuleyJLZhangKMcCullersJA 2010 The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis. J Virol 84 558 564

31. HaiRMartinez-SobridoLFraserKAAyllonJGarcia-SastreA 2008 Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach. J Virol 82 10580 10590

32. Fernandez-SesmaAMarukianSEbersoleBJKaminskiDParkMS 2006 Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol 80 6295 6304

33. FranchiLEigenbrodTNunezG 2009 Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation. J Immunol 183 792 796

34. FodorEDevenishLEngelhardtOGPalesePBrownleeGG 1999 Rescue of influenza A virus from recombinant DNA. J Virol 73 9679 9682

35. NakayaTCrosJParkMSNakayaYZhengH 2001 Recombinant Newcastle disease virus as a vaccine vector. J Virol 75 11868 11873

36. GaoQParkMSPaleseP 2008 Expression of transgenes from newcastle disease virus with a segmented genome. J Virol 82 2692 2698

37. MaamaryJArrayFGaoQGarcia-SastreASteinmanRM 2011 Newcastle disease virus expressing a dendritic cell-targeted HIV gag protein induces a potent gag specific immune response in mice. J Virol 85 2235 46

38. RamosIBernal-RubioDDurhamNBelicha-VillanuevaALowenAC 2011 Effects of receptor binding specificity of avian influenza virus on the human innate immune response. J Virol 85 4421 31

39. NiwaHYamamuraKMiyazakiJ 1991 Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108 193 199

40. ParkMSShawMLMunoz-JordanJCrosJFNakayaT 2003 Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol 77 1501 1511

41. BrunsKStudtruckerNSharmaAFossenTMitznerD 2007 Structural characterization and oligomerization of PB1-F2, a proapoptotic influenza A virus protein. J Biol Chem 282 353 363

42. KatoHTakeuchiOSatoSYoneyamaMYamamotoM 2006 Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441 101 105

43. HayeKBurmakinaSMoranTGarcia-SastreAFernandez-SesmaA 2009 The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells. J Virol 83 6849 6862

44. Garcia-SastreAEgorovAMatassovDBrandtSLevyDE 1998 Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252 324 330

45. HaleBGRandallREOrtinJJacksonD 2008 The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89 2359 2376

46. MibayashiMMartinez-SobridoLLooYMCardenasWBGaleMJr 2007 Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 81 514 524

47. OnoguchiKOnomotoKTakamatsuSJogiMTakemuraA 2010 Virus-infection or 5′ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog 6 e1001012

48. XuYZhongHShiW 2010 MAVS protects cells from apoptosis by negatively regulating VDAC1. Mol Cell Biochem [Epub ahead of print]

49. Le GofficRBouguyonEChevalierCVidicJDa CostaB 2010 Influenza A Virus Protein PB1-F2 Exacerbates IFN-beta Expression of Human Respiratory Epithelial Cells. J Immunol 185 4812 23

50. WiseHMFoegleinASunJDaltonRMPatelS 2009 A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J Virol 83 8021 8031

51. YamadaHChounanRHigashiYKuriharaNKidoH 2004 Mitochondrial targeting sequence of the influenza A virus PB1-F2 protein and its function in mitochondria. FEBS Lett 578 331 336